SMITHS GROUP SERVICES CORPORATION for SMITHS GROUP SERVICES CORPORATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 17, 2015 | $560,000 | Replaced |
| 1st Quarter - Amendment | Apr 17, 2015 | $560,000 | Yes |
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Aviation/Airlines/Airports AVI
Aviation security solutions and detection technologies for the Transportation Security Administration (TSA). International standards for aviation security.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH PRESSNELL | — |
Environment/Superfund ENV
Issues related to climate change. Issues related to emissions technologies.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS SWONGER | — |
Defense DEF
FY2016 National Defense Authorization. FY2016 Department of Defense Appropriations; chemical and biological counter measures. Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and detection solutions for the Department of Defense.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Taxation/Internal Revenue Code TAX
Issues related to tax reform. International tax issues. Issues related to the repeal of the medical device excise tax.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
| CHRIS SWONGER | — |
Budget/Appropriations BUD
Funding for aviation security and homeland security technologies. FY2016 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding issues. FY2016 Department of Defense Appropriations; chemical and biological counter measures. FY2016 Departments of Labor, Health and Human Services, and Education Appropriations; medical device funding and policy. Monitor the following: FY2014 Department of Defense Appropriations Act (H.R.2397/S.1429); chemical and biological counter measures. FY2015 Departments of Labor, Health and Human Services, and Education Appropriations; Health care delivery system initiatives.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH PRESSNELL | — |
| KEVIN SCHMIDT | — |
| CHRIS SWONGER | — |
Energy/Nuclear ENG
S.1, Keystone XL Pipeline Approval Act and H.R.3, Keystone XL Pipeline Act; issues related to approval of Keystone Pipeline. Issues related to energy infrastructure.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS SWONGER | — |
Homeland Security HOM
Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS) and U.S. Customs and Border Protection (CBP). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions. FY2016 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding issues.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH PRESSNELL | — |
Medical/Disease Research/Clinical Labs MED
H.R.160, Protect Medical Innovation Act of 2015, S.149, Medical Device Access and Innovation Protection Act, H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; issues related to patient infusion therapy.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
| CHRIS SWONGER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.